Skip to main content
The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · IEX Real-Time Price · USD
0.524
+0.004 (0.77%)
At close: Jul 19, 2024, 4:00 PM
0.560
+0.036 (6.87%)
Pre-market: Jul 20, 2024, 9:28 AM EDT

The Oncology Institute Revenue

The Oncology Institute had revenue of $342.71M in the twelve months ending March 31, 2024, with 25.30% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $94.67M with 24.25% year-over-year growth. In the year 2023, The Oncology Institute had annual revenue of $324.24M with 28.42% growth.

Revenue (ttm)
$342.71M
Revenue Growth
+25.30%
P/S Ratio
0.11
Revenue / Employee
$428,391
Employees
800
Market Cap
39.01M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023324.24M71.76M28.42%
Dec 31, 2022252.48M49.48M24.37%
Dec 31, 2021203.00M15.49M8.26%
Dec 31, 2020187.52M32.11M20.66%
Dec 31, 2019155.41M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nortech Systems 138.66M
Concord Medical Services Holdings 75.80M
electroCore 18.69M
Curis 9.81M
Co-Diagnostics 6.68M
Dyadic International 2.26M
Revenue Rankings

TOI News

More News